======= CMAS ======= == Gene Information == * **Official Symbol**: CMAS * **Official Name**: cytidine monophosphate N-acetylneuraminic acid synthetase * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=55907|55907]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q8NFW8|Q8NFW8]] * **Interactions**: [[https://thebiogrid.org/search.php?search=CMAS&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20CMAS|Open PubMed]] * **OMIM**: [[https://omim.org/entry/603316|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Catalyzes the activation of N-acetylneuraminic acid (NeuNAc) to cytidine 5'-monophosphate N-acetylneuraminic acid (CMP-NeuNAc), a substrate required for the addition of sialic acid. Has some activity toward NeuNAc, N-glycolylneuraminic acid (Neu5Gc) or 2-keto-3-deoxy-D-glycero-D-galacto-nononic acid (KDN). |NTP transf 3| |CTP transf 3| |N-acylneuraminate cytidylyltransferase activity| |N-acetylneuraminate metabolic process| |amino sugar metabolic process| |antibiotic metabolic process| |drug metabolic process| |carboxylic acid metabolic process| |oxoacid metabolic process| |organic acid metabolic process| |carbohydrate derivative metabolic process| |small molecule metabolic process| |membrane| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp356|Docosahexaenoic-acid 50μM R07 exp356]]|-2.26| |[[:results:exp321|ABT-702 5μM plus Deferoxamine 11μM R07 exp321]]|-1.99| |[[:results:exp224|CB-839 10μM R05 exp224]]|-1.86| |[[:results:exp164|Q15 1 to 2μM on day4 R04 exp164]]|-1.81| |[[:results:exp485|GSK626616 14μM R08 exp485]]|1.71| |[[:results:exp400|Senexin-A 25μM R07 exp400]]|1.74| |[[:results:exp498|Lead acetate 2000μM R08 exp498 no dilution day6]]|1.79| |[[:results:exp418|Tunicamycin 0.04μM R07 exp418]]|1.8| |[[:results:exp122|Golgicide-A 4μM R03 exp122]]|1.84| |[[:results:exp80|RO-3307 4.7μM R02 exp80]]|1.94| |[[:results:exp505|ML-792 0.2μM R08 exp505]]|2.07| |[[:results:exp429|Rapamycin 0.001μM R08 exp429]]|2.1| |[[:results:exp82|Torin1 0.08μM R02 exp82]]|2.11| |[[:results:exp489|Hippuristanol 0.12μM R08 exp489 no dilution day6]]|2.13| |[[:results:exp75|MK-1775 0.32μM R02 exp75]]|2.24| |[[:results:exp510|Nicotine 3000μM R08 exp510]]|2.26| |[[:results:exp30|Rapamycin 10μM R00 exp30]]|2.29| |[[:results:exp233|EPZ-5676 30μM R05 exp233]]|2.57| |[[:results:exp524|Staurosporine 0.02μM R08 exp524]]|2.59| |[[:results:exp234|Ethanol 0.01 R05 exp234]]|2.69| |[[:results:exp407|Thapsigargin 0.005μM R07 exp407]]|2.71| |[[:results:exp246|UM0011500 10μM R05 exp246]]|2.72| |[[:results:exp189|Temozolomide 200μM R04 exp189]]|2.79| |[[:results:exp66|BI-D1870 3.15μM R02 exp66]]|2.82| |[[:results:exp504|MK2206 4μM R08 exp504]]|2.95| |[[:results:exp488|Hippuristanol 0.12μM R08 exp488]]|3.22| |[[:results:exp85|UM0129480 7μM R02 exp85]]|3.33| |[[:results:exp90|WYE-354 6μM R02 exp90]]|3.79| |[[:results:exp216|Erlotinib 10μM R05 exp216]]|4.25| ^Gene^Correlation^ |[[:human genes:n:nans|NANS]]|0.486| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 10547 * **Expression level (log2 read counts)**: 4.49 {{:chemogenomics:nalm6 dist.png?nolink |}}